Answers are grounded in this paper and cite their sources.
Clinical exome sequencing is frequently used to identify gene-disrupting variants in individuals with neurodevelopmental disorders. While splice-disrupting variants are known to contribute to these disorders, clinical interpretation of cryptic splice variants outside of the canonical splice site has been challenging. Here, we discuss papers that improve such detection.
No takes yet. Share an insight, caveat, or question.
Sanders et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: